Warren Jaworowicz is the head of Technical Development and Manufacturing at TScan.  He joined TScan in February of 2020.

Warren brings more than 25 years of industry experience developing and commercializing small molecule, protein, and cell and gene therapy therapeutics to this role.  Warren has held leadership roles in process development, manufacturing, supply chain, and CMC program management and has experience at both early stage and commercial organizations.

Previously, Warren was Sr. Director at Editas Medicine where he played a pivotal role in establishing their CMC function and bringing the fist in vivo CRISPR therapy to the clinic.  Earlier in his career, Warren held various positions at large and small biotech companies including Shire (now Takeda), Stryker Biotech, and Alkermes.